Papers to be published in forthcoming issues
A case of systemic histoplasmosis diagnosed in a peripheral blood smear
Bone marrow granulomas in Salmonella paratyphi A infection
An infectious aetiology for childhood acute leukaemia
Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia
Multiple myeloma involving central nervous system
Effects of PRIMA-1 on chronic lymphocytic leukaemia cells with and without hemizygous p53 deletion
Expression of protein gene product 9·5 (PGP9·5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells
A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK
Prognostic significance of hepatocyte growth factor and c-MET expression in patients with diffuse large B-cell lymphoma
Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance
Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation
Measuring T cell immunity to influenza vaccination in children after haemopoietic stem cell transplantation
Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents
Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells
Human bone marrow adipocytes support complete myeloid and lymphoid differentiation from human CD34+ cells
Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine
Development of Duffy transgenic mouse
Prophylactic use of deferiprone (L1) and magnetic resonance imaging T2* or T2 for preventing heart disease in thalassaemia
Prophylactic use of deferiprone (L1) and magnetic resonance imaging T2* or T2 for preventing heart disease in thalassaemia
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders
PK Aarau
Pain from myelofibrosis treated with regular pamidronate
Clonal karyotypic abnormalities in Philadelphia negative cells of CML patients treated with imatinib